10th Annual Risk Management and Pharmacovigilance Summit

10 – 11 May 2023 | Vienna

REGISTER NOW
REQUEST PROGRAMME

SPEAKERS

Summit will host speakers from the world’s leading companies

Andrea Oliva

Head of Pharmacovigilance, Italy

Petros Mavrogenis

Head Vigilance Process Excellence

Khaudeja Bano

VP Combination Product Quality

Birna Kristín Eiríksdóttir

Associate Director, Senior Pharmacovigilance Scientist

Majken Berghuis

Pharmacovigilance Director

Hottest topics that will be discussed this annual

Pharmacovigilance System determines the future of the drug. The market demands the unequivocal necessity that the product used to treat the disease does not harm the patient in such a way that the quality of life is further diminished. Identification, minimisation and prevention of risk, as well as its communication to publicity, is one of the fundamental wings of the topic. Detect issues, discover the latest solutions, and share the experience with top experts within the industry at our interactive conference.
The 10th Annual Risk Management and Pharmacovigilance Summit aims to set the vector of your professional development in 2023. This time we bring senior-level decision-makers together to share their thoughts on the different angles of the topic. The concept of digital, AI, vendor management, new essential pharmacovigilance requirements, data collection and protection, patient safety & risk management, signal management, and proactive monitoring are the key points to discuss.

Cover Over 6 Topics

  • What is the role of digital media and Artificial Intelligence (AI)? How do we go digital?
  • How can companies achieve better results and practical usage of digital tools in their PV process?
  • Difference of Good Pharmacovigilance Practices (GVP) interpretation between generic traditional and innovation modules in the pharma sector
  • How to build effective metrics for vendor oversight. Partnership performance on outgoing bases
  • Patient safety & risk management for pharmacovigilance and drug safety
  • What are the new essential pharmacovigilance requirements in the EU and UK regulations?

Very relevant topics from everyday practicalities to more visionary. Experienced & knowledgeable speakers. I really liked the quality of topics and their usefulness

Pfizer– Senior Director Safety Risk Lead

Very good conference with a friendly atmosphere and a panel of very good experts. Discussions were very lively and open

Sanofi– Head of QPPV Office

Good event where pharma companies can exchange experience. I got a very good overview about the hot topics in PV and current needs and developments

Vifor Pharma– Head Clinical Drug Safety

The right amount of participants allowing for good interaction between peers. Interesting topics with studies

Takeda– Associate Director, PV Compliance

Few photos from our summits

Event programme

Fill your details in the form and we will
send you the whole brochure filled with all details

Your copy of the brochure is prepared.

Inside you will find

  • What keynote speakers will be taking part in the exclusive speaking panel
  • What Case Studies will be discussed by our senior corporate speakers
  • The minute by minute breakdown of the conference